Sick of ‘Me-too’ Pharma, Upsher-Smith Laboratories Shops for Biotech

Upsher-Smith Laboratories Inc. has taken a 7.1 percent stake in a British firm developing a treatment for Parkinson’s disease, marking the pharmaceutical company’s first big step into expanding beyond the generic drug market.